Fierce Biotech Homepage

liver
Favicon Fierce Biotech

Roche becomes MASH player via $3.5B deal for 89bio, ph. 3 drug

Roche dived into the MASH space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate.
James Waldron Sep 18, 2025 5:02am
team layoffs workforce
Favicon Fierce Biotech

Pfizer, Arvinas lose interest in commercializing PROTAC drug

Sep 18, 2025 7:35am
reducing people on team
Favicon Fierce Biotech

ArsenalBio halves staff amid reorganization efforts

Sep 17, 2025 4:55pm
A stethoscope resting on flag of USA
Favicon Fierce Biotech

Massachusetts most impacted by NIH research cuts: Grant Witness

Sep 18, 2025 9:38am
obesity overweight weight loss weigh
Favicon Fierce Biotech

QL Biopharm links monthly GLP-1 to incumbent-rivaling efficacy

Sep 18, 2025 7:20am
GSK

GSK plots $30B investment in US manufacturing, R&D

Sep 16, 2025 7:01pm
More News

HHS taps 5 new members for CDC vaccine panel

Sep 15, 2025 3:46pm

Under Trump, FDA seeks to abandon expert reviews of new drugs

Sep 12, 2025 9:50am

Nominations open for Fiercest Women in Life Sciences 2025

Sep 12, 2025 7:00am

Novo Nordisk tells employees they must return to office Jan. 1

Sep 11, 2025 2:13pm